Polymorphisms of the β2-adrenergic receptor determine exercise capacity in patients with heart failure

Circulation Research

Volumn 86, Issue 8, 2000, Pages 834-840

  Wagoner, Lynne E ^a   Craft, Laura L ^a   Singh, Balkrishna ^a   Suresh, Damodhar P ^a   Zengel, Paul W ^a   McGuire, Nancy ^a   Abraham, William T ^a   Chenier, Thomas C ^a   Dorn II, Gerald W ^a   Liggett, Stephen B ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Exercise; Genetics; Heart failure; adrenergic receptors

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ADULT; ARTICLE; EXERCISE; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HEART FAILURE; HEART INDEX; HEART STROKE VOLUME; HEMODYNAMICS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SYSTEMIC VASCULAR RESISTANCE;

EID: 17444439098     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.86.8.834     Document Type: Article

References (18)

1. 2-adrenergic receptor in normal and asthmatic subjects. Am J Respir Cell Mol Biol. 1993;8:334-339.
2. 2-adrenergic receptor within the fourth transmembrane domain alters ligand binding and functional properties of the receptor. J Biol Chem. 1993;268:23116-23121.
3. 2-adrenergic receptor impart distinct agonist-promoted regulatory properties. Biochemistry. 1994;33:9414-9419.
4. 2-adrenergic receptor function. J Allergy Clin Immunol. 1999;103:S42-S46.
5. 2-adrenergic receptor polymorphism expressed in transgenic mice. Proc Natl Acad Sci U S A. 1996;10483-10488.
6. Bristow MR. Why does the myocardium fail?: insights from basic science. Lancet. 1998;352(suppl I):S18-S14.
7. 2-adrenergic receptor polymorphisms adversely affects the outcome of congestive heart failure. J Clin Invest. 1998;102:1534-1539.
8. Mancini DM, Eisen H, Kussmaul W, Mull R, Edmunds LH, Wilson JR. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation. 1991;83:778-786.
9. Packer M, Pitt B. Which objective measurements parallel the course of disease progression in patients with congestive heart failure? J Am Coll Cardiol. 1988;11:202A. Abstract.
10. White M, Yanowitz F, Gilbert EM, Larrabee P, O'Connell JB, Anderson JL, Renlund D, Mealey P, Abraham WT, Bristow MR. Role of beta-adrenergic receptor downregulation in the peak exercise response in patients with heart failure due to idiopathic dilated cardiomyopathy. Am J Cardiol. 1995;76:1271-1276.
11. 2-adrenergic receptor genotypes on signal transduction in human airway smooth muscle cells. Am J Respir Cell Mol Biol. 1995;13:25-33.
12. 2-adrenoceptor polymorphism with lower airway reactivity in asthmatic subjects. Lancet. 1995;345:1213-1214.
13. Martinez FD, Graves PE, Baldini M, Solomon S, Erickson R. Association between genetic polymorphisms of the beta2-adrenoceptor and response to albuterol in children with and without a history of wheezing. J Clin Invest. 1997;100:3184-3188.
14. Timmermann B, Mo R, Luft FC, Gerdts E, Busjahn A, Omvik P, Li GH, Schuster H, Wienker TF, Hoehe MR, Lund-Johansen P. Beta-2 adrenoreceptor genetic variation is associated with genetic predisposed essential hypertension: the Bergen Blood Pressure Study. Kidney Int. 1998;53: 1455-1460.
15. 2-adrenoceptor. Hypertension. 1997;30:773-776.
16. Miller LW. Listing criteria for cardiac transplantation: results of an American Society of Transplant Physicians-National Institutes of Health Conference. Transplantation. 1998;66:947-951.
17. Moore RL, Korzick DH. Cellular adaptations of the myocardium to chronic exercise. Prog Cardiovasc Dis. 1995;37:371-396.
18. Mancini DM. Pulmonary factors limiting exercise capacity in patients with heart failure. Prog Cardiovasc Dis. 1995;37:347-370.